Concepedia

Michael Murawsky

MM

Statistics

Publications

17

Citations

670

H-Index

14

Active since

1981

Affiliations

University of Cincinnati Medical Center(Current)

University of Cincinnati

Procter & Gamble (United States)

United States Food and Drug Administration

The Ohio State University at Marion

Michael Murawsky is an author at University of Cincinnati Medical Center specializing in pharmacology, medicine, and potassium channel blockers.

Publications per year

1981–2020

17

Publications

17

The Antipsychotic Agent Sertindole is a High Affinity Antagonist of the Human Cardiac Potassium Channel HERG

David Rampe, Michael Murawsky, Eric Lewis · Journal of Pharmacology and Experimental Therapeutics · 1998 · 175 citations

Medicine, Cardiology, Pharmacology +15

Transepidermal water loss and skin conductance as barrier integrity tests

Qian Zhang, Michael Murawsky, Terri D. LaCount et al. · Toxicology in Vitro · 2018 · 63 citations

Nursing, Dermatology, Photodermatology +13

Cytotoxicity of cardioplegic solutions: evaluation by tissue culture.

Stéphane Carpentier, Michael Murawsky, Alain Carpentier · PubMed · 1981 · 58 citations

Medicine, Cardiology, Toxicology +13

Discovery and in vitro/in vivo studies of tetrazole derivatives as Kv1.5 blockers

Shengde Wu, Andrew Fluxe, Jim Sheffer et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 52 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +6

Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist

Bruce M. Baron, Boyd L. Harrison, John H. Kehne et al. · European Journal of Pharmacology · 1997 · 48 citations

Medicine, Medicinal Chemistry, Pharmacology +13

1–5 of 17